Skip to main content
. 2020 Sep 17;10(3):132. doi: 10.3390/jpm10030132

Table 3.

Prediction of tumor response to NAC using MTVcsc in HER2-positive/TN vs. luminal subtypes.

HER2-Positive/TN (N = 82) Luminal (N = 38)
pCR (N = 22) Residual
Tumor (N = 60)
pCR (N = 0) Residual
Tumor (N = 38)
MTVcsc < 1.75 cm3 22 21 0 27
MTVcsc > 1.75 cm3 0 39 0 11
Prediction accuracy 74% (61/82) 29% (11/38)